Drug research

VSJ-110

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyeNCT07179055	Vanda Pharmaceuticals	Phase 2	Recruiting	2026-09Estimated
A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyeNCT06296966	Vanda Pharmaceuticals	Phase 2	Unknown	2024-07Estimated
Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular AllergiesNCT04622345	Vanda Pharmaceuticals	Phase 2	Completed	2021-05-22Actual

Vanda PharmaceuticalsRecruitingPrimary completion: 2026-09 · Estimated

Trial details

Vanda PharmaceuticalsUnknownPrimary completion: 2024-07 · Estimated

Trial details

Vanda PharmaceuticalsCompletedPrimary completion: 2021-05-22 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.